Skip to Content

Cambia Approval History

  • FDA approved: Yes (First approved June 17th, 2009)
  • Brand name: Cambia
  • Generic name: diclofenac potassium
  • Dosage form: for Oral Solution
  • Previous name: PRO-513
  • Company: Kowa Pharmaceuticals America, Inc.
  • Treatment for: Migraine

Cambia (diclofenac potassium) is a non-steroidal anti-inflammatory drug combined with potassium bicarbonate for the treatment of acute migraine with or without aura in adults.

Development History and FDA Approval Process for Cambia

Jun 23, 2009Approval FDA Approves Cambia for Migraine
Dec 12, 2007ProEthic Pharmaceuticals Announces Acceptance of PRO-513 New Drug Application for Migraine

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.